Outlook Therapeutics, Inc.OTLKEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Outlook Therapeutics, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing ophthalmic biologic therapies for patients with unmet medical needs. Its core pipeline targets common sight-threatening eye conditions, with operations spanning North America, Europe, and key Asia-Pacific regional markets.